Neurable, a neurotechnology startup racing to embed brain-monitoring technology into everyday devices, closed a $35 million Series A funding round led by Spectrum Moonshot Fund, signaling investor confidence that consumer brain-computer interface innovation is ready to scale beyond the lab.

The capital raise brings Neurable’s total funding to $65 million, doubling the company’s resources since a $13 million round last year. But this Series A represents something more significant than dollars. It marks the moment when non-invasive brain monitoring, long dismissed as inferior to surgically implanted alternatives, became a viable market category, particularly for applications where comfort and accessibility matter more than raw signal strength.

“We’re at an inflection point,” said Dr. Ramses Alcaide, CEO and co-founder of Neurable. “The MW75 Neuro LT headphones prove you can give people real brain insights through devices they actually want to wear.”

The Signal-Quality Tradeoff

Neurable’s timing exploits a fundamental division in neurotechnology. Invasive brain chips, exemplified by Neuralink’s recent $650 million Series E, offer superior signal resolution, enabling thought-to-text applications for paralyzed patients. Meanwhile, non-invasive wearable BCIs rely on electroencephalography (EEG) sensors placed on the scalp, capturing weaker but sufficient data for cognitive monitoring.

This distinction creates two separate markets. Invasive approaches dominate high-stakes medical interventions, where the clinical benefits justify the surgical risks. Non-invasive alternatives capture the growing wellness and consumer gaming segments where people prioritize comfort over precision.

Neurable positions itself at the commercial center of this second market. Rather than chasing paralysis patients like Neuralink or Precision Neuroscience, the company targets gamers, office workers, and researchers seeking real-time insights into focus, fatigue, and cognitive recovery, metrics that drive competitive advantage in esports and workplace productivity.

The company’s MW75 Neuro LT headphones, launched in September 2024 in partnership with audio manufacturer Master & Dynamic, embed Neurable AI, the company’s proprietary brain-signal processing algorithm, directly into active noise-canceling headsets.

Independent peer-reviewed studies validate the system’s ability to detect focus states and cognitive load with high fidelity. For gamers, this means quantifiable feedback on mental performance during ranked matches. For researchers, it means capturing human attention data at scale without laboratory equipment.

Market Momentum Makes $35M Rational

The capital raise reflects genuine market expansion. The global brain-computer interface market is roughly $2.6 billion to $3.2 billion in 2025, projected to reach $12.4 billion to $12.9 billion by 2034, representing a compound annual growth rate of 14 to 17 percent. Gaming specifically shows steeper curves: the BCI gaming segment crossed $144 million in 2024 and is forecast to hit $927 million by 2034.

This growth isn’t speculative. Venture funding in neurotechnology hit $2.3 billion in 2024, more than tripling from 2022 levels. Cognitive health wearables, the category Neurable pioneered, are predicted to expand from $2.5 billion in 2025 to $8.7 billion by 2031.

Notably, Neurable is the first non-invasive BCI startup to raise this amount of capital. Competitors like EMOTIV (founded 2011, $7 million-plus in funding) and Cognixion pursue similar consumer-wearable strategies but have not achieved comparable Series A valuations.

This gap suggests investors see something distinctive in Neurable’s execution: credible peer-reviewed validation, celebrity-grade hardware partnerships, and a laser focus on gaming, where even incremental cognitive performance gains translate to tournament rankings and sponsorship dollars.

“Gaming is one of the most intuitive applications of Neurable AI,” said Adam Molnar, co-founder and VP of Strategic Partnerships at Neurable. “Players constantly push their cognitive limits. Brain insights tell them exactly when they’re peaking.”

The Strategic Expansion Play

With this capital, Neurable plans to scale its AI platform across new devices and industries beyond headphones. The company is already collaborating with iMotions, the largest human-behavior research platform, to embed its headsets into commercial research workflows.

A partnership with MeSpace investigates how adaptive workstations affect cognitive performance, an enterprise wellness angle that opens B2B revenue channels independent of consumer hardware.

Existing investors Pace Ventures, Ultratech Capital Partners, TRAC, and Metaplanet reaffirmed their support, signaling confidence in Alcaide’s roadmap.

Neurable’s funding validates a broader technology thesis: the future of brain-computer interfaces won’t be defined by invasive implants alone. Non-invasive wearables solve a different problem, they make neuroscience data ambient, available without surgery, and integrated into devices people already use. As artificial intelligence improves at interpreting EEG signals, the sensitivity gap narrows.

This doesn’t threaten companies like Neuralink. Instead, it confirms that BCIs are fragmenting into parallel markets: clinical intervention (invasive), consumer wellness (non-invasive), and professional performance (non-invasive). Neurable chose the latter two.

For founders and operators tracking this space, the lesson is clear. In 2025, neurotechnology stopped being a speculative frontier and began to look like infrastructure.

Follow USTechTimes on Facebook, Twitter and Linkedin for in-depth news of market trends, funding updates, and regulatory changes affecting startups in USA.

We Recommend: